0 CHECKOUT

PRODUCT FILTERS

REGION

13
4
3
3
3

COUNTRY

PRICE

3
41
63
137

PUBLISHED

0
25
55
137

PRODUCT TYPE

127
4
3
3

Lymphoma Drugs

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

Global T-Cell Lymphoma Market & Clinical Pipeline Insight

Immune system consists of various cells that impart resistance to body against foreign entities. They also prevent the development of aberrant cells in the body to maintain its normal functioning. However,...

Published:  March 2016
Price:  From

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing...

Published:  November 2014
Price:  From

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances,...

Published:  June 2014
Price:  From

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing...

Published:  August 2014
Price:  From

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016 Summary The report ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016’, provides an overview of the Anaplastic Large...

Published:  February 2016
Price:  From

Lymphoma Drug Pathway Analyzer

Extra value: One year of free online updates included with this product There are today at least 516 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways...

Published:  February 2016
Price:  From

Target Atlas in Lymphoma: A Competitive Outlook

Extra value: One year of free online updates included with this product "Target Atlas in Lymphoma: A Competitive Outlook" helps you to understand the complex world of commercial development in lymphoma...

Published:  February 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016 Summary ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)...

Published:  March 2016
Price:  From

Indolent Lymphoma - Pipeline Review, H1 2016

Indolent Lymphoma - Pipeline Review, H1 2016 Summary ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape. The report provides comprehensive...

Published:  February 2016
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H1 2016

Mantle Cell Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. The report...

Published:  February 2016
Price:  From

Hodgkin Lymphoma - Pipeline Review, H1 2016

Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report provides...

Published:  February 2016
Price:  From

Non-Hodgkin Lymphoma - Pipeline Review, H2 2015

Non-Hodgkin Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

Burkitt Lymphoma - Pipeline Review, H2 2015

Burkitt Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Burkitt Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline. This report provides...

Published:  December 2015
Price:  From

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2015

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s...

Published:  December 2015
Price:  From

Follicular Lymphoma - Pipeline Review, H2 2015

Follicular Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Follicular Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2015

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2015 Summary The report ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic...

Published:  December 2015
Price:  From

Lymphoma Drug Pipeline Update

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 369 companies plus partners developing 521 lymphoma drugs in 949 developmental projects in cancer....

Published:  February 2016
Price:  From

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients